Viewing Study NCT04074993


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2025-12-25 @ 11:27 PM
Study NCT ID: NCT04074993
Status: UNKNOWN
Last Update Posted: 2023-09-28
First Post: 2019-08-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Brigatinib in ALK-positive NSCLC Identified Via Blood-based Assays
Sponsor: JI-YOUN HAN
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module